"Michael Davoli, senior government relations director for ACS CAN, stated that roughly 1 million cancer survivors live in New York, with about 132,000 new diagnoses expected this year. He emphasized that biomarker testing 'gives them hope' and criticized the governor for 'trying to balance the budget on the backs of cancer patients.'"
"Advocates argue that the proposed language in the executive budget would limit the types of evidence that trigger coverage for biomarker tests, narrowing the clinical guidelines or peer-reviewed studies that count when deciding Medicaid payment."
Cancer survivors and advocates gathered outside Gov. Kathy Hochul's office to demand the preservation of Medicaid coverage for biomarker testing. They argue that proposed changes in the executive budget would limit access to these tests, which are crucial for targeted cancer therapies. Advocates warn that narrowing eligibility criteria would disproportionately affect Medicaid patients compared to those with private insurance, exacerbating existing racial and economic disparities in healthcare access. The American Cancer Society Cancer Action Network organized the demonstration to mobilize support for maintaining coverage.
Read at Hoodline
Unable to calculate read time
Collection
[
|
...
]